SARRECCHIA, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 10.512
EU - Europa 870
AS - Asia 207
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 4
Totale 11.603
Nazione #
US - Stati Uniti d'America 10.509
IT - Italia 167
CN - Cina 144
UA - Ucraina 142
DE - Germania 115
FR - Francia 92
SE - Svezia 88
IE - Irlanda 87
PL - Polonia 85
FI - Finlandia 33
GB - Regno Unito 31
KR - Corea 30
BE - Belgio 10
RU - Federazione Russa 10
JP - Giappone 6
VN - Vietnam 6
AU - Australia 5
CH - Svizzera 5
HK - Hong Kong 5
IN - India 5
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
SG - Singapore 3
CA - Canada 2
EU - Europa 2
KG - Kirghizistan 2
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
MN - Mongolia 1
NL - Olanda 1
NO - Norvegia 1
NP - Nepal 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 11.603
Città #
Woodbridge 3.207
Wilmington 2.823
Houston 2.497
Fairfield 364
Chandler 268
Ann Arbor 221
Ashburn 155
Seattle 137
Cambridge 116
Jacksonville 116
Kraków 85
Dublin 82
Rome 76
Medford 63
Dearborn 62
New York 61
Zhengzhou 47
Beijing 41
Milan 33
Lawrence 29
Menlo Park 20
San Diego 18
Boardman 14
Palo Alto 14
San Francisco 13
Mülheim 12
Nanjing 11
Shanghai 11
Brussels 10
Phoenix 10
Verona 10
Creede 8
Falls Church 8
Dong Ket 6
Hefei 6
London 6
Kunming 5
Redwood City 5
University Park 5
Helsinki 4
Hong Kong 4
Nanchang 4
Auburn Hills 3
Chengdu 3
Colorado Springs 3
Guangzhou 3
Jinan 3
Lausanne 3
Mountain View 3
Santa Clara 3
São Paulo 3
Arezzo 2
Bagnoregio 2
Binasco 2
Canberra 2
Engelhard 2
Fuzhou 2
Guiyang 2
Göttingen 2
Monte Vista 2
Novokuznetsk 2
Redmond 2
Roebling 2
San Jose 2
Zurich 2
Amsterdam 1
Apo 1
Avellino 1
Bangalore 1
Baotou 1
Bari 1
Bobrynets 1
Buffalo 1
Cassino 1
Cedarhurst 1
Central 1
Chicago 1
Chieti 1
Chongqing 1
Council Bluffs 1
Dhaka 1
Gambettola 1
Indiana 1
Jaipur 1
Kathmandu 1
Kemerovo 1
L'aquila 1
La Canada Flintridge 1
Lake Forest 1
Melbourne 1
Montréal 1
North Hollywood 1
Norwalk 1
Nuremberg 1
Oslo 1
Perugia 1
Pune 1
Riyadh 1
Rocca Massima 1
Roseau 1
Totale 10.777
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 489
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 437
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 437
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 420
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. 419
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 419
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. 415
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 411
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 407
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 406
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 401
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 400
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 397
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 397
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 392
Multidrug resistance after lamivudine therapy for chronic hepatitis B 390
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb 386
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 381
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance 366
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. 365
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 359
Aciclovir, herpes viruses and HIV: a never-ending story 357
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 350
Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen 345
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. 344
Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon 338
Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients 320
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 315
Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype 305
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection 302
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 228
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 16
Therapy and prevention of infective endocarditis 8
Totale 11.722
Categoria #
all - tutte 19.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019907 0 0 0 0 0 0 0 0 0 288 328 291
2019/20203.139 268 237 225 277 255 361 311 272 268 252 189 224
2020/20211.798 207 212 215 227 171 204 221 173 35 50 64 19
2021/2022441 24 36 36 22 4 32 21 13 103 33 15 102
2022/2023608 54 65 54 92 41 118 35 54 51 7 25 12
2023/2024146 31 2 11 4 6 66 0 14 4 8 0 0
Totale 11.722